Diluted EPS came in at $-37.95, missed the $-5.50 consensus by $32.45.
Trailing eight quarters through Q4 2024
Common questions about Mustang Bio's Q4 2024 earnings report.
Mustang Bio (MBIO) reported Q4 2024 earnings on March 24, 2025 before market open.
Mustang Bio reported diluted EPS of $-37.95 for Q4 2024.
EPS missed the consensus estimate of $-5.50 by $32.45.
You can read the 10-K periodic report (0001558370-25-003913) directly on SEC EDGAR. The filing index links above go to sec.gov.